New Jersey Dispensaries Push Back on THC Potency Obsession

The Counter Rush at New Jersey Dispensaries

Walk into most New Jersey dispensaries today and the first question budtenders hear is "What's your highest THC?" The fixation has become so routine that some retailers have begun retraining staff to redirect the conversation toward terpenes, cannabinoid ratios, and desired effects rather than raw potency numbers.

Budtenders report that customers routinely dismiss strains testing below 25% THC, even when those cultivars offer richer terpene profiles or more suitable cannabinoid balances for their stated needs. The pattern is particularly pronounced among newer consumers entering the market since New Jersey launched adult-use sales in 2022.

Why Retailers Say the Potency Race Hurts Quality

The chase for high-THC flower is incentivizing growers to prioritize potency over other quality markers, according to dispensary operators. Strains known for complex terpene bouquets or balanced cannabinoid profiles often test in the 18-22% THC range—a tier many shoppers now skip entirely.

Some cultivators have responded by selecting phenotypes and harvest windows that maximize THC at the expense of flavor, aroma, and entourage effect. The result? A narrowing product lineup that prioritizes lab numbers over consumer experience.

Testing Variance Fuels the Confusion

New Jersey's cannabis testing protocols allow for natural variance, but many consumers treat the printed THC percentage as an absolute measure of quality. A single cultivar can test anywhere from 19% to 24% THC depending on the batch, the lab, and even the specific bud sampled for compliance testing.

That variance means two jars of the same strain, grown by the same producer, can carry different potency labels yet deliver nearly identical effects. Budtenders say explaining this nuance at the counter is an uphill battle when customers are primed to shop by the highest number on the shelf.

Terpenes Take a Back Seat

Terpene content—the aromatic compounds that shape flavor and modulate effects—is often printed in smaller type or relegated to a secondary panel on New Jersey packaging. Myrcene, limonene, and caryophyllene levels can be more predictive of a strain's subjective effects than THC alone. Few consumers know to ask.

Some dispensaries have begun featuring terpene breakdowns on in-store menus and digital displays, hoping to elevate the conversation. Early adopters report modest success, particularly with repeat customers willing to experiment beyond the highest-THC option.

The Entourage Effect Explained (Again)

The entourage effect—the synergistic interaction of cannabinoids, terpenes, and flavonoids—remains underappreciated in mainstream consumer behavior. Research suggests that a 20% THC flower with solid terpene content can deliver a more satisfying experience than a stripped-down 30% THC product, but translating that science into a 90-second counter interaction isn't easy.

Retailers are experimenting with side-by-side sampling programs and educational signage to demonstrate that potency is only one variable in a multi-dimensional product.

What Dispensaries Are Doing Differently

A handful of New Jersey retailers have restructured their menus to de-emphasize THC percentage and foreground effect categories, terpene profiles, and lineage. Strategies include:

• Grouping flower by desired effect (energizing, relaxing, balanced) rather than potency tier
• Printing terpene percentages in the same font size as THC on shelf tags
• Training budtenders to ask about use case before recommending products
• Offering small-format samplers that let customers compare high-THC and terpene-forward options side by side

The pivot requires buy-in from both staff and supply-chain partners, and early results are mixed. Some customers appreciate the guided approach. Others still default to asking for "the strongest thing you have."

The Path Forward for Consumer Education

Industry observers say shifting the potency narrative will require coordinated effort from regulators, retailers, and cultivators. Potential interventions include standardized terpene reporting on all packaging, public education campaigns funded by cannabis tax revenue, and revised testing protocols that account for total cannabinoid and terpene content rather than THC alone.

For now, the work falls largely to budtenders. What's the next signal to watch? Whether New Jersey's Cannabis Regulatory Commission issues updated labeling guidance that elevates terpene data to equal prominence with potency figures. Until then, the highest-THC jar will likely remain the fastest mover on most dispensary shelves.